Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?-Reference-Cited by-同舟云学术

Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?

Published:2020-04 Issue:4 Volume:145 Page:1153-1156
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Eiwegger Thomas,Anagnostou Katherine,Arasi Stefania,Bégin Philippe,Ben-Shoshan Moshe,Beyer Kirsten,Blumchen Katharina,Brough Helen,Caubet Jean-Christoph,Chan Edmond S.,Chen Meng,Chinthrajah Sharon,Davis Carla M.,Des Roches Anne,Du Toit George,Elizur Arnon,Galli Stephen J.,Håland Geir,Hoffmann-Sommergruber Karin,Kim Harold,Leung Donald Y.M.,Long Andrew,Muraro Antonella,Nurmatov Ulugbek B.,Pajno Giovanni B.,Sampath Vanitha,Saxena Jamie,Sindher Sayantani,Upton Julia,Worm Margitta,Nadeau Kari C.

Funder

Stanford University

Food Allergy Research & Education

DBV Technologies

Fonds de Recherche en Santé du Québec

National Institutes of Health

NIAMS

United States–Israel Binational Foundation

NIH/NIAMS

NIH/NIAID

National Center for Research Resources

Publisher